Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · IEX Real-Time Price · USD
0.525
-0.021 (-3.83%)
At close: Jul 19, 2024, 4:00 PM
0.524
-0.001 (-0.23%)
Pre-market: Jul 22, 2024, 7:41 AM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $21.61 million as of July 22, 2024. Its market cap has decreased by -74.36% in one year.
Market Cap
21.61M
Enterprise Value
-55.65M
1-Year Change
-74.36%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since the IPO on October 9, 2020, Spruce Biosciences's market cap has decreased from $333.95M to $21.61M, a decrease of -93.53%. That is a compound annual growth rate of -51.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 21.60M | -81.89% |
| Dec 29, 2023 | 119.30M | 362.40% |
| Dec 30, 2022 | 25.80M | -75.33% |
| Dec 31, 2021 | 104.60M | -81.46% |
| Dec 31, 2020 | 564.30M | 68.98% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunoPrecise Antibodies | 21.97M |
| Minerva Neurosciences | 21.96M |
| Gain Therapeutics | 21.84M |
| Aprea Therapeutics | 21.72M |
| OneMedNet | 21.70M |
| Viracta Therapeutics | 21.50M |
| Forte Biosciences | 21.50M |
| TherapeuticsMD | 21.22M |